NEW

COVID-19 Granulocytes

Granulocytes from acute & recovered COVID-19 patients obtained with Ficoll density gradient. Sample made available upon request. Please contact [email protected] to obtain this product. US customers only.

[Price not listed]  
CoV-Granulocyte

Product Specifications

Size:
Granulocyte layer from 50 cc of whole blood (1 patient)
Background:
During Ficoll density gradient centrifugation, granulocytes (neutrophils, basophils, eosinophils) form a layer separate from peripheral blood mononuclear cells (PBMCs). The granulocyte layer is directly above the red blood cells. Thus, when this layer is collected, red blood cells will be present. After isolating this layer, RayBiotech will lyse the red blood cells. The number of granulocytes obtained per patient will vary. All cells will be provided to customer; the number of provided cells cannot be guaranteed.
Species:
Human
Sample Type:
Granulocytes (treated with red blood cell lysis buffer)
Anticoagulant:
EDTA
Format:
Frozen with 10% DMSO
Shipping temperature:
Shipped on dry ice
Biosafety Level:
2
Note: While the patients were confirmed to have COVID-19 via a test detecting either SARS-CoV-2 virus or viral proteins using a nasopharyngeal swab, these samples have not been tested for the presence of virus or any other diseases and should be assumed infectious.

No posts found

Write A Review

Usage

This product is furnished for LABORATORY RESEARCH USE ONLY.
Not for diagnostic or therapeutic use.